Results 101 to 110 of about 23,180 (193)

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

Infection and Drug Resistance, 2012
Marisa H Miceli1, Pranatharthi Chandrasekar21Oakwood Hospital and Medical Center, Dearborn, 2Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Liposomal amphotericin B is a "true&quot ...
Miceli MH, Chandrasekar P
doaj  

Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy

Journal of Vector Borne Diseases
In the current scenario, treatment of Post kala-azar dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in the efficacy of miltefosine and a rise in permanent loss of ...
Sushruta Kathuria, Yugansh Gautam, Niti Khunger, Shruti Sharma, Ruchi Singh   +4 more
doaj   +1 more source

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Revista da Sociedade Brasileira de Medicina Tropical
Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema.
Maria Antonia Ferreira Gomes, Lana Lira Cantidio de Medeiros, Fernanda Paula Dantas Lobo, Nathália Rayane Silva Wanderley, Ana Paula Rodrigues Matos, Tácito do Nascimento Jácome, Maria Goretti Lins Monteiro, Kleber Giovanni Luz   +7 more
doaj   +1 more source

Amphotericin-B-liposomal

Reactions Weekly, 2022
  +6 more sources

ENDEMIC MYCOSES PROGRAM IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS): CASE CHARACTERIZATION AND PHARMACOECONOMIC IMPACT IN A HIGH-COMPLEXITY UNIVERSITY HOSPITAL

Brazilian Journal of Infectious Diseases
Introduction/Objectives: The Ministry of Health Endemic Mycoses Program is essential in SUS, ensuring access to high-cost antifungals for patients with systemic fungal infections, according to RENAME and Clinical Protocols and Therapeutic Guidelines ...
Andressa Barros, Gilian Batista Balbueno Guerreiro, Maitê Roxo dos Santos, Lucia Collares Meirelles   +3 more
doaj   +1 more source

The use of K39 test in the diagnosis of visceral leishmaniasis [PDF]

, 2007
From time to time patients admitted with fever of unknown origin prove to be a diagnostic dilemma. While textbooks describe typical symptoms and signs, and also diagnostic tests, these are not always helpful.
Sciberras, Robert
core  

Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis [PDF]

, 1996
The efficacy of AmBisome, a liposomal formulation of amphotericin B, was compared with that of Fungizone (amphotericin B desoxycholate), in a rat model of unilateral, pulmonary aspergillosis.
Bakker-Woudenberg, I.A.J.M. (Irma), Kate, M.T. (Marian) ten, Leenders, A.C.A.P. (Alexander), Marie, S. (Siem) de, Verbrugh, H.A. (Henri)   +4 more
core  

Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. [PDF]

, 2019
Black, J, Boulware, D, Boyles, T, Chiller, T, Dawood, H, Dlamini, S, Govender, NP, Harrison, TS, Ive, P, Jarvis, J, Karstaedt, A, Madua, MC, Mangena, P, Meintjes, G, Menezes, C, Moosa, M-YS, Motlekar, Z, Nel, J, Potgieter, S, Rabie, H, Reddy, D, Shroufi, A, Stacey, SL, Tsitsi, M, van Cutsem, G, Variava, E, Venter, M, Wake, R, Wilson, D   +28 more
core   +2 more sources

Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome

Iranian Journal of Parasitology
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment.
Mahmoud Khodabandeh, Elham Moradian, Maedeh Sarvari, Mahsa Soti Khiabani   +3 more
doaj  

Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence

Indian Journal of Dermatology
Post-kala-azar dermal leishmaniasis (PKDL) is a neglected skin disease that has tremendous epidemiological significance as a reservoir of Leishmania parasites. Relapse, drug resistance, non-compliance to prolonged treatment, poor health-seeking behaviour,
Alka Kumari, Niyamat A. Siddiqui, Sweta Kumari, Krishna Murti, Rishikesh Kumar, Krishna Pandey, Somanaboina Padmakar, Biplab Pal   +7 more
doaj   +1 more source